SEC Filing Analysis: ALBEMARLE CORP (ALB)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Chief Commercial Officer receives routine RSU grant vesting in 2029.
• Market Impact: Neutral; standard compensation activity.

Company Information

Field	Value
Company	ALBEMARLE CORP
Ticker Symbol	ALB
CIK	0000915913
Market Cap	$19.85B

Insider Information

Field	Value
Name	Norris Eric
CIK	0001624621
Title/Position	Chief Commercial Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-02
Transaction Code	A (Grant)
Security Type	Common Stock
Shares Involved	4,490
Price Per Share	$0.00
Total Value	$0.00
Shares Owned After	53,443
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Grant)
% of Market Cap	0.00%
Shares Transacted	4,490
% of Shares Outstanding	0.0038%
Materiality Assessment	Low

Impact Evaluation

• Dilution Impact: The grant represents 0.0038% of the 117.7M shares outstanding, resulting in negligible dilution.
• Vesting Terms: Footnotes indicate these Restricted Stock Units vest 100% on 03/02/2029, serving as a long-term retention incentive.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a standard compensation event (Transaction Code 'A') and does not reflect open market sentiment or immediate insider conviction.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Timing: Grant date of March 2, 2026.
• Special Circumstances: Award is subject to a 3-year cliff vesting schedule.